Shannon Thyme Klinger, Chief Legal Officer at Moderna, Inc. (MRNA), sold 1,340 shares at $94.57 ($127K) on 2024-02-29, disclosed to the SEC on 2024-03-01.
Scheduled sale ($127k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.57 | 670 | $63K | 50.0% |
| 2 | $94.57 | 670 | $63K | 50.0% |
| Total | $94.57 avg | 1,340 | $127K | 100% |
| Filing → |
| MRNA | SELL | 2026-03-03 | $726K | — | Filing → |
| MRNA | SELL | 2024-12-10 | $24K | — | Filing → |
| MRNA | SELL | 2024-12-04 | $5K | — | Filing → |